Opioid receptor trafficking and signaling: What happens after opioid receptor activation?

Cellular and Molecular Neurobiology

Volumn 32, Issue 2, 2012, Pages 167-184

  Bian, Jia Ming ^a,b   Wu, Ning ^a   Su, Rui Bin ^a   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cellular adaptation; Dependence; Morphine; Opioid receptor; Tolerance

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENYLATE CYCLASE; ANTISENSE OLIGONUCLEOTIDE; BETA ARRESTIN 1; BETA ARRESTIN 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; METHADONE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE RECEPTOR; PROTEIN KINASE C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADAPTATION; AMINO TERMINAL SEQUENCE; ANALGESIC ACTIVITY; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL NUCLEUS; DRUG MECHANISM; DRUG TOLERANCE; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEEDBACK SYSTEM; HUMAN; INTERNALIZATION; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MORPHINE ADDICTION; NONHUMAN; OLIGOMERIZATION; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; RECEPTOR DOWN REGULATION; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; WITHDRAWAL SYNDROME;

ANIMALS; ENDOCYTOSIS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 84864697635     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9755-5     Document Type: Review

References (189)

1. Abel T, Nguyen PV, Barad M, Deuel TAS, Kandel ER, Bourtchouladze R (1997) Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88:615-626
2. Abiria SA, Colbran RJ (2010) CaMK II associates with Cav1.2 L-type calcium channels via selected β subunits to enhance regulatory phosphorylation. J Neurochem 112:150-161
3. Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP Kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135-163
4. Allouche S, Polsatron J, Jauzac P (1996) The delta-opioid receptor regulates activity of ryanodine receptors in the human neuroblastoma cell line SK-N-BE. J Neurochem 67:2461-2470
5. γ in hippocampal long-term potentiation depends on activation of metabotropic glutamate receptors. Neuroscience 93:1289-1295
6. Aragay AM, Ruiz-Gòmez A, Penela P, Sarnago S, Elorza A, Jiménez-Sainz MC, Mayor F Jr (1998) G protein-coupled receptor kinase2 (GRK2): mechanisms of regulation and physiological functions. FEBS Lett 430:37-40
7. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT (2006) Separation of opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci 26:4118-4125
8. Bailey CP, ConnorM(2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68
9. Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G (2003) Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. J Neurosci 23:10515-10520
10. Bailey CP, Kelly E, Henderson G (2004) Protein kinase C activation enhances morphine-Induced rapid desensitization of μ-opioid receptors in mature rat locus coeruleus neurons. Mol Pharmacol 66:1592-1598
11. Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, Henderson G (2009) Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci 29:307-318
12. 2+ store in the plasticity of central neurons. Trends Pharmacol Sci 27:78-84
13. Belcheva MM, Coscia CJ (2002) Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11:34-44
14. βγ subunits. J Neurochem 70:635-645
15. Bilecki W, Zapart G, Ligȩza A, Wawrzczak-Bargiela A, Urbański MJ, Przewłocki R (2005) Regulation of the extracellular signalregulated kinases following acute and chronic opioid treatment. Cell Mol Life Sci 62:2369-2375
16. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999) Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286:2495-2498
17. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) l-Opioid receptor desensitization by β-arrestin2 determines morphine tolerance but not dependence. Nature 408:720-723
18. Bohn LM, Lefkowitz RJ, Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in β-arrestin2 knock-out mice. J Neurosci 22:10494-10500
19. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG (2003) Enhanced rewarding properties of morphine, but not cocaine, in β-arrestin2 knockout mice. J Neurosci 23:10265-10273
20. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS (2004) Relative opioid efficacy is determined by the components of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 66:106-112
21. Bourinet E, Soong TW, Stea A, Snutch TP (1996) Determinants of the G protein-dependent opioid modulation of neuronal calcium channels. Proc Natl Acad Sci USA 93:1486-1491
22. Braun AP, Schulman H (1995) The multifunctional calcium/ calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol 57:417-445
23. Bushell T, Endoh T, Simen AA, Ren D, Bindokas VP, Miller RJ (2002) Molecular components of tolerance to opiates in single hippocampal neurons. Mol Pharmacol 61:55-64
24. Cao JL, He JH, Ding HL, Zeng YM (2005) Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 118:336-349
25. Caunt CJ, Finch AR, Sedgley KR, McArdle CA (2006) Seventransmembrane receptor signaling and ERK compartmentalization. Trends Endocrinol Metab 17:276-283
26. Celver J, Xu M, Jin W, Lowe J, Chavkin C (2004) Distinct domains of the μ-opioid receptor control uncoupling and internalization. Mol Pharmacol 65:528-537
27. Chakrabarti S, Gintzler AR (2007) Phosphorylation of Gas influences its association with the μ-opioid receptor and is modulated by long-term morphine exposure. Mol Pharmacol 72:753-760
28. Chakrabarti S, Oppermann M, Gintzler AR (2001) Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci USA 98:4209-4214
29. Chakrabarti S, Regec A, Gintzler AR (2005a) Chronic morphine acts via a protein kinase Cγ-Gβ-adenylyl cyclase complex to augment phosphorylation of Gβ and Gβγ stimulatory adenylyl cyclase signaling. Mol Brain Res 138:94-103
30. Chakrabarti S, Regec A, Gintzler AR (2005b) Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. Mol Brain Res 135:217-224
31. 2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends in Neurosci 22:12-16
32. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356:521-523
33. Chu J, Zheng H, Loh HH, Law PY (2008) Morphine-induced μ-opioid receptor rapid desensitization is independent of receptor phosphorylation and β-arrestins. Cell Signal 20:1616-1624
34. Chung I, Schlichter LC (1997) Native Kv1.3 channels are upregulated by protein kinase C. J Membr Biol 156:73-85
35. Clapham DE, Neer EJ (1997) G protein βγ subunits. Annu Rev Pharmacol Toxicol 37:167-203
36. Cooper CB, Arnot MI, Feng ZP, Jarvis SE, Hamid J, Zamponi GW (2000) Cross-talk between G-protein and protein kinase C modulation of N-type calcium channels is dependent on the G-protein β subunit isoform. J Biol Chem 275:40777-40781
37. Cvejic S, Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964
38. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ (1997) Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem 272:19125-19132
39. Dhillon AS, von Kriegsheim A, Grindlay J, Kolch W (2007) Phosphatase and feedback regulation of Raf-1 signaling. Cell Cycle 6:1-7
40. Diaz A, Pazos A, Florez J, Ayesta FJ, Santana V, Hurle MA (2002) Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin2 in the rat brain after chronic opioid receptor antagonism. Neuroscience 112:345-353
41. Ding Q, Gros R, Gray ID, Taussig R, Ferguson SSG, Feldman RD (2004) Raf kinase activation of adenylyl cyclases: isoformselective regulation. Mol Pharmacol 66:921-928
42. Dupré DJ, Robitaille M, Rebois RV, Hébert TE (2009) The role of Gbc subunits in the organization, assembly, and function of GPCR signaling complexes. Annu Rev Pharmacol Toxicol 49: 31-56
43. Ebisuya M, Kondoh K, Nishida E (2005) The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci 118: 2997-3002
44. Eisinger DA, Ammer H (2008) δ-Opioid receptors activate ERK/ MAP kinase via integrin-stimulated receptor tyrosine kinases. Cell Signal 20:2324-2331
45. El Kouhen R, Kouhen OM, Law PY, Loh HH (1999) The absence of a direct correlation between the loss of [D-Ala2, MePhe4, Gly5-ol] Enkephalin inhibition of adenylyl cyclase activity and agonistinduced μ-opioid receptor phosphorylation. J Biol Chem 274: 9207-9215
46. Elliot K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE (1994) The NMDA receptor antagonists, LY274614 and MK-801, and the nitricoxide synthease inhibitor, NG-nitro-Larginine, attenuate analgesic tolerance to the μ-opioid morphine but not to kappa opioids. Pain 56:69-75
47. English JD, Sweatt JD (1997) A requirement for the mitogenactivated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272:19103-19106
48. 2+ channels. Neuroscience 54:401-407
49. Fan XL, Zhang JS, Zhang XQ, Yue W, Ma L (2003) Differential regulation of b-arrestin 1 and b-arrestin 2 gene expression in rat brain by morphine. Neuroscience 113:383-389
50. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR (2005) A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of l and d opioid receptor hetero-oligomers. J Biol Chem 280:38478-38488
51. Ferrer-Alcón M, García-Fuster MJ, Harpe RL, García-Sevilla JA (2004) Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the prefrontal cortex of human opiate addicts. J Neurochem 90:220-230
52. 2+ current modulation during recovery of neuroblastoma cells from pertussis toxin pretreatment. FEBS lett 334:322-326
53. Gabra BH, Bailey CP, Kelly E, Sanders AV, Henderson G, Smith FL, Dewey WL (2007) Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance. Brain Res 1159:86-93
54. Gabra BH, Bailey CP, Kelly E, Smith FL, Henderson G, Deweya WL (2008) Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Res 1217:70-77
55. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF (2000) Oligomerization of mu- and delta-opioid receptors: generation of novel functional properties. J Biol Chem 275: 26128-26135
56. George SR, O'Dowd BF, Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820
57. 286 of the α calcium-calmodulin kinase II in LTP and learning. Science 279:870-873
58. Gintzler AR, Chakrabarti S (2006) Post opioid receptor adaptations to chronic morphine: altered functionality and associations of signaling molecules. Life Sci 79:717-722
59. Girault JA, Valjent E, Caboche J, Herve D (2007) ERK2: a logical and gate critical for drug-induced plasticity? Curr Opin Pharmacol 7:77-85
60. Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S et al (1999) Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9:369-372
61. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors. J Neurosci 20:RC110
62. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of l and d opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 101: 5135-5139
63. 2+. Cell Signal 20:359-374
64. Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD et al (2000) Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275:27354-27359
65. Guo J, Wu Y, Zhang W, Zhao J, Devi LA, Pei G, Ma L (2000) Identification of G protein-coupled receptor kinase2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. Mol Pharmacol 58:1050-1056
66. Harrison LM, Kastin AJ, Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19: 1603-1630
67. He L, Whistler JL (2005) An opiate cocktail that reduces morphine tolerance and dependence. Curr Biol 15:1028-1033
68. He L, Fong J, von Zastrow M, Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282
69. 2+ channels by G-protein βγ subunits. Nature 380:258-262
70. Hilger RA, Scheulen ME, Strumberg D (2002) The Ras-Raf-MEKERK pathway in the treatment of cancer. Onkologie 25:511-518
71. Hurle MA (2001) Changes in the expression of G protein-coupled receptor kinases and b-arrestin2 in rat brain during opioid tolerance and supersensitivity. J Neurochem 77:486-492
72. Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M et al (2001) MEK kinase activity is not necessary for Raf-1 function. EMBO J 20:1940-1951
73. Hyman SE (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162:1414-1422
74. Ignatova EG, Belcheva MM, Bohn LM, Neuman MC, Coscia CJ (1999) Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J Neurosci 19:56-63
75. Ikeda SF (1996) Voltage-dependent modulation of N-type calcium channels by Gbc-protein subunits. Nature 380:225-258
76. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21:869-883
77. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA et al (1996) Essential role of b-adrenergic receptor kinase1 in cardiac development and function. Proc Natl Acad Sci USA 93: 12974-12979
78. Javed RR, Dewey WL, Smith PA, Smith FL (2004) PKC and PKA inhibitors reverse tolerance to morphine-induce hypothermia and supraspinal analgesia in mice. Eur J Pharmacol 492:149-157
79. Jiang B, Shi Y, Li H, Kang L, Ma L (2006) Decreased morphine analgesia in rat overexpressingβ-arrestin2 at periaqueductal gray. Neurosci Lett 400:150-153
80. Johnson EA, Oldfield S, Ellen Braksator, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G (2006) Agonist-selective mechanisms of μ-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 70:676-685
81. Jones MB, Siderovski DP, Hooks SB (2004) The Gβγ dimer as a novel source of selectivity in G-protein signaling: GGL-ing at convention. Mol Interv 4:200-214
82. Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700
83. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413
84. Kang H, Sun LD, Atkins CM, Soderling TR, Wilson MA, Tonegawa S (2001) An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory. Cell 106:771-783
85. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-857
86. Kelleher RJ III, Govindarajan A, Jung HY, Kang H (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116:467-479
87. Kim JA, Bartlett S, He L, Nielsen CK, Chang AM, Kharazia V, Waldhoer M, Ou CJ, Taylor S, Ferwerda M, Cado D, Whistler JL (2008) Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 18:129-135
88. Kim SM, Ahn SM, Go BS, Wang JQ, Choe ES (2009) Alterations in AMPA receptor phosphorylation in the rat striatum following acute and repeated cocaine administration. Neuroscience 163: 618-626
89. Ko SW, Jia Y, Xu H, Yim SJ, Jang DH et al (2006) Evidence for a role of CaMKIV in the development of opioid analgesic tolerance. Eur J Neurosci 23:2158-2168
90. Kramer HK, Simon EJ (1999) Role of protein kinase C (PKC) in agonist-induced μ-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by μ-opioid agonists. J Neurochem 72:585-593
91. Kramer HK, Simon EJ (2000) l and d-opioid receptor agonists induce mitogen activated protein kinase(MAPK) activation in the absence of receptor internalization. Neuropharmacology 39:1707-1719
92. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ (1997) CREB (cAMP response element binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901
93. Law PY, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430
94. Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by β-arrestins. Science 308:512-517
95. Lefkowitz RJ, Pierce K, Luttrell LM (2002) Dancing with different partners: protein kinase A phosphorylation of seven membranespanning receptors regulates their G protein-coupling specificity. Mol Pharmacol 62:971-974
96. Leonard AS, Hell JW (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-Methyl-D-aspartate receptors at different sites. J Biol Chem 272:12107-12115
97. Li JL, Xiang B, Su WJ, Zhang XQ, Huang YL, Ma L (2003) Agonistinduced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-Gβγ complex on membrane is required for GRK2 function in vivo. J Biol Chem 278:30219-30226
98. Li T, Yan CX, Hou Y, Cao W, Chena T, Zhu BF, Li SB (2008) Cueelicited drug craving represses ERK activation in mice prefrontal association cortex. Neurosci Lett 448:99-104
99. Liu AMF, Wong YH (2005) Mu-opioid receptor-mediated phosphorylation of IjB kinase in human neuroblastoma SH-SY5Y cells. Neurosignals 14:136-142
100. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623
101. Lou LG, Pei G (1997) Modulation of protein kinase C and cAMPdependent protein kinase by δ-opioid. Biochem Biophys Res Commun 236:626-629
102. Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y (2005) Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 8:212-219
103. Luttrell LM, Lefkowitz RJ (2002) The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455-465
104. Ma L, Pei G (2007) β-arrestin signaling and regulation of transcription. J Cell Sci 120:213-218
105. MacKenzie SJ, Baillie GS, McPhee I, MacKenzie C, Seamons R, McSorley T, Millen J, Beard MB, van Heeke G, Houslay MD (2002) Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A mediated phosphorylation of a single serine residue in Upstream Conserved Region1 (UCR1). Br J Pharmacol 136:421-433
106. Maeda T, Hamabe W, Gao Y, Fukazawa Y, Kumamoto K, Ozaki M, Kishioka S (2005) Morphine has an antinociceptive effect through activation of the okadaic-acid-sensitive Ser/Thr protein phosphatases PP2A and PP5 estimated by tail-pinch test in mice. Brain Res 1056:191-199
107. Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5-21
108. Mansuy IM (2003) Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun 311:1195-1208
109. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ (1995) Increases in protein kinase C gamma immunoreactivity in the spinal cord of rat associated with tolerance to the analgesic effects of morphine. Brain Res 677:257-267
110. Mathews JL, Smrcka AV, Bidlack JM (2008) A novel Gβλ-subunit inhibitor selectively modulates μ-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence. J Neurosci 28:12183-12189
111. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K et al (1996) Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the l opioid receptor gene. Nature 383:819-823
112. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609
113. McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S et al (2010) l-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78:756-766
114. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, Milligan G (2001) Monitoring receptor oligomerization using timeresolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099
115. 2+ channel: from discovery to new signaling concepts. J Neurochem 102:1426-1446
116. Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J et al (2001) Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20:1952-1962
117. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7
118. Milligan G (2006) G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov Today 11:541-549
119. Morice C, Nothias F, Konig S, Vernier P, Baccarini M, Vincent JD, Barnier JV (1999) Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain. Eur J Neurosci 11:1995-2006
120. Moulédous L, Díaz MF, Gutstein HB (2007) Extracellular signalregulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse. Pharmacol Biochem Behav 88:39-46
121. Nestler EJ (2004) Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210-218
122. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63
123. Nevo I, Avidor-Reiss T, Levy R, Bayewitch M, Vogel Z (2000) Acute and chronic activation of the μ-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology 39:364-371
124. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210
125. Oancea E, Meyer T (1998) Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 95: 307-318
126. Oe K, Narita M, Imai S, Shibasaki M, Kubota C et al (2004) Inhibition of the morphine-induced rewarding effect by direct activation of spinal protein kinase C in mice. Psychopharmacology 177:55-60
127. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Dunb NJ, Tsenga LF (2003) Involvement of b-arrestin-2 in modulation of the spinal antinociception induced by μ-opioid receptor agonists in the mouse. Neurosci Lett 346:13-16
128. Onprishvili I, Andria ML, Kramer H, Ancevska-Taneva N, Hiller JM, Simon EJ (2003) Interaction between the l opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol Pharmacol 64:1092-1100
129. Ozaita A, Escriba PV, Ventayol P, Murga C, Mayor F Jr, Garcia-Sevilla JA (1998) Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J Neurochem 70:1249-1257
130. Pert CB, Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179:1011-1014
131. Philip JSS, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266
132. 2+ channel and adenylyl cyclase modulation by cloned μ-opioid receptors in GH3 cells. Mol Pharmacol 47:1041-1049
133. 2+ channels by cloned μ-and d-opioid receptors. Mol Pharmacol 50:947-956
134. Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G protein-coupled receptor kinase. Annu Rev Biochem 67:653-692
135. Polakiewicz R, Schieferl SM, Dorner LF, Kansra V, CombMJ (1998) A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J Biol Chem 273:12402-12406
136. Pritchard CA, Bolin L, Slattery R, Murray R, McMahon M (1996) Post natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol 6:614-617
137. Przewlocka B, Sieja A, Starowicz K, Maj M, Bilecki W, Przewlocki R (2002) Knockdown of spinal opioid receptors by antisense targeting b-arrestin reduces morphine tolerance and allodynia in rat. Neurosci Lett 325:107-110
138. Pumiglia KM, LeVine H, Haske T, Habib T, Jove R, Decker SJ (1995)A direct interaction between G-protein beta gamma subunits and the Raf-1 protein kinase. J Biol Chem 270:14251-14254
139. Rhim H, Miller RJ (1994) Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J Neurosci 14:7608-7615
140. Ribas C, Penela P, Murga C, Salcedo A, García-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F Jr (2007) The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768:913-922
141. Roth NS, Campbell PT, Caron MG, Lefkowitz RJ, Lohse MJ (1991) Comparative rates of desensitization of β-adrenergic receptors by the b-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci USA 88:6201-6204
142. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-344
143. Rushworth LK, Hindley AD, O'Neill E, Kolch W (2006) Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol 26:2262-2272
144. Saito N, Shirai Y (2002) Protein kinase Cγ (PKCγ): function of neuron specific isotype. J Biochem 132:683-687
145. Schallmach E, Steiner D, Vogel Z (2006) Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure. Neuropharmacology 50: 998-1005
146. Schulz R, Wehmeyer A, Schulz K (2002) Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J Pharmacol Exp Ther 300:376-384
147. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Höllt V (2004) Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23:3282-3289
148. Schwindinger WF, Robishaw JD (2001) Heterotrimeric G-protein βγ-dimers in growth and differentiation. Oncogene 20:1653-1660
149. Shy M, Chakrabarti S, Gintzler AR (2008) Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment. Mol Pharmacol 73:868-879
150. Slupsky JR, Quitterer U, Weber CK, Gierschik P, Lohse MJ, Rapp UR (1999) Binding of Gβγ subunits to cRaf1 downregulates G-protein coupled receptor signalling. Curr Biol 9:971-974
151. Smart TG (1997) Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr Opin Neurobiol 7:358-387
152. + currents. Br J Pharmacol 116:2655-2660
153. 2+ in rat intracardiac ganglion neurones. Neurosci Lett 264:105-108
154. Smith FL, Gabra BH, Smith PA, Redwood MC, Dewey WL (2007) Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain 127:129-139
155. 2+-calmodulin-dependent protein kinase cascade. Trends Biochem 24:232-235
156. Steinera D, Sayaa D, Schallmacha E, Simonds WF, Vogel Z (2006) Adenylyl cyclase type-VIII activity is regulated by Gbc subunits. Cell Signal 18:62-68
157. Strittmatter SM, Igarashi M, Fishman MC (1994) GAP-43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neurosci 14:5503-5513
158. Sun Y, McGarrigle D, Huang XY (2007) When a G protein-coupled receptor does not couple to a G protein. Mol BioSyst 3:849-854
159. Sunahara RK, Taussig R (2002) Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol Interv 2:168-184
160. Sunahara RK, Dessauer CW, Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480
161. Szucs M, Boda K, Gintzler AR (2004) Dual effects of Tyr-D-Ala-Gly-(NMe) Phe-Gly-ol (DAMGO) and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) on adenylyl cyclase activity: implications for μ-opioid receptor Gs coupling. J Pharmacol Exp Ther 310:256-262
162. Tang WJ, Hurley JH (1998) Catalytic mechanism and regulation of mammalian adenylyl cyclases. Mol Pharmacol 54:231-240
163. Tang TS, Tu H, Wang Z, Bezprozvanny I (2003) Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase A and protein phosphatase 1α. J Neurosci 23:403-415
164. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, Chavkin C (2004) G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 141:55-64
165. Terwilliger RZ, Ortiz J, Guitart X, Nestler EJ (1994) Chronic morphine administration increases b-adrenergic receptor kinase (bARK) levels in the rat locus coeruleus. J Neurochem 63: 1983-1986
166. Tumati S, Milnes TL, Yamamura HI, Vanderah TW, Roeske WR, Varga EV (2008) Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Eur J Pharmacol 601:207-208
167. Tzivion G, Luo Z, Avruch J (1998) A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394:88-92
168. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19:1826-1836
169. Velázquez KT, Mohammad H, Sweitzer SM (2007) Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res 55: 578-589
170. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73-82
171. Wagner EJ, Rønnekleiv OK, Kelly MJ (1998) Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling. J Pharmacol Exp Ther 285:1266-1273
172. Wang HL (2000) A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization. Neuropharmacology 39: 353-363
173. Wang ZJ, Tang L, Xin L (2003) Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)/calmodulindependent protein kinase II. Eur J Pharmacol 465:199-200
174. Watts VJ (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7
175. Watts VJ, Neve KA (2005) Sensitization of adenylate cyclase by Gai/o-coupled receptors. Pharmacol Ther 106:405-421
176. Wayman GA, Tokumitsu H, Soderling TR (1997) Inhibitory crosstalk by cAMP kinase on the calmodulin-dependent protein kinase cascade. J Biol Chem 272:16073-16076
177. Wayman GA, Lee YS, Tokumitsu H, Silva A, Soderling TR (2008) Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron 59:914-931
178. Whistler JL, von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by b-arrestin. Proc Natl Acad Sci USA 95:9914-9919
179. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746
180. 2+ channels. J Neurosci 15:4124-4132
181. Winklhofer M, Matthias K, Seifert G, Stocker M, Sewing S, Herget T, Steinhäuser C, Saaler-Reinhardt S (2003) Analysis of phosphorylation- dependent modulation of Kv1.1 potassium channels. Neuropharmacology 44:829-842
182. Wojnowski L, Zimmer AM, Beck TW, Hahn H, Bernal R, Rapp UR, Zimmer A (1997) Endothelial apoptosis in B-raf-deficient mice. Nat Genet 16:293-297
183. Yue X, Varga EV, Stropova D, Vanderah TW, Yamamura HI, Roeske WR (2006) Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074. Eur J Pharmacol 540:57-59
184. Zalk R, Lehnart SE, Marks AR (2007) Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem 76: 367-385
185. Zeitz KP, Malmberg AB, Gilbert H, Basbaum AI (2001) Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice. Pain 94:245-253
186. 2+ release channels by Gbc. Curr Biol 13:872-876
187. Zhang J, Ferguson SSG, Barak LS, Bodduluri SR, Laporte SA, Law PY, Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162
188. Zheng H, Loh HH, Law PY (2008) b-arrestin-dependent μ-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation. Mol Pharmacol 73:178-190
189. Zuo Z (2005) The role of opioid receptor internalization and β-arrestins in the development of opioid tolerance. Anesth Analg 101:728-734